second-generation TLR-9 agonist (Pfizer)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namesecond-generation TLR-9 agonist (Pfizer)
Drug Alias NameSecond-generation TLR-9 agonist (Pfizer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesColey Pharmaceutical Group Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A